Tetra-substituted heteroaryl compounds and their use as MDM2 and/or MDM4 modulators

Details for Australian Patent Application No. 2010288534 (hide)

Owner Novartis AG

Inventors Bold, Guido; Furet, Pascal; Gessier, Francois; Kallen, Joerg; Hergovich Lisztwan, Joanna; Masuya, Keiichi; Vaupel, Andrea

Agent Davies Collison Cave

Pub. Number AU-A-2010288534

PCT Pub. Number WO2011/023677

Priority 61/237,107 26.08.09 US

Filing date 24 August 2010

Wipo publication date 3 March 2011

International Classifications

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/84 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/88 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

15 March 2012 PCT application entered the National Phase

  PCT publication WO2011/023677 Priority application(s): WO2011/023677

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010288542-IL-17 binding compounds and medical uses thereof

2010288528-Aqueous suspension concentrate formulations containing saflufenacil